Literature DB >> 1544174

Serum opsonins and liposomes: their interaction and opsonophagocytosis.

H M Patel1.   

Abstract

Removal of intravenously injected liposomes from the circulation is achieved by cells of the mononuclear phagocyte system, also known as the reticuloendothelial system. On exposure to blood, liposomes become coated with plasma proteins; some of these proteins (opsonins) are thought to determine their recognition by mononuclear phagocytes. This review provides a critical discussion of factors that control opsonization of liposomes and their phagocytosis in vivo and in vitro.

Mesh:

Substances:

Year:  1992        PMID: 1544174

Source DB:  PubMed          Journal:  Crit Rev Ther Drug Carrier Syst        ISSN: 0743-4863            Impact factor:   4.889


  34 in total

Review 1.  Recognition by macrophages and liver cells of opsonized phospholipid vesicles and phospholipid headgroups.

Authors:  S M Moghimi; A C Hunter
Journal:  Pharm Res       Date:  2001-01       Impact factor: 4.200

Review 2.  Immunological risk of injectable drug delivery systems.

Authors:  Wim Jiskoot; Rianne M F van Schie; Myrra G Carstens; Huub Schellekens
Journal:  Pharm Res       Date:  2009-02-27       Impact factor: 4.200

3.  Ligands located within a cholesterol domain enhance gene delivery to the target tissue.

Authors:  Long Xu; Jamie Betker; Hao Yin; Thomas J Anchordoquy
Journal:  J Control Release       Date:  2012-03-09       Impact factor: 9.776

4.  Biodistribution and Toxicity of X-Ray Iodinated Contrast Agent in Nano-emulsions in Function of Their Size.

Authors:  Mohamed F Attia; Nicolas Anton; Roman Akasov; Manuela Chiper; Elena Markvicheva; Thierry F Vandamme
Journal:  Pharm Res       Date:  2015-10-28       Impact factor: 4.200

5.  Effect of polyethyleneglycol-phospholipids on aggregate structure in preparations of small unilamellar liposomes.

Authors:  K Edwards; M Johnsson; G Karlsson; M Silvander
Journal:  Biophys J       Date:  1997-07       Impact factor: 4.033

6.  Liposomal Irinotecan Accumulates in Metastatic Lesions, Crosses the Blood-Tumor Barrier (BTB), and Prolongs Survival in an Experimental Model of Brain Metastases of Triple Negative Breast Cancer.

Authors:  Afroz S Mohammad; Jessica I Griffith; Chris E Adkins; Neal Shah; Emily Sechrest; Emma L Dolan; Tori B Terrell-Hall; Bart S Hendriks; Helen Lee; Paul R Lockman
Journal:  Pharm Res       Date:  2018-01-09       Impact factor: 4.200

Review 7.  Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.

Authors:  Long Xu; Thomas Anchordoquy
Journal:  J Pharm Sci       Date:  2011-01       Impact factor: 3.534

8.  Nano to micro delivery systems: targeting angiogenesis in brain tumors.

Authors:  Ariel Gilert; Marcelle Machluf
Journal:  J Angiogenes Res       Date:  2010-10-08

9.  Effects of chitosan coating on physical properties and pharmacokinetic behavior of mitoxantrone liposomes.

Authors:  Jie Zhuang; Qineng Ping; Yunmei Song; Jianping Qi; Zheng Cui
Journal:  Int J Nanomedicine       Date:  2010-08-09

10.  Direct suppression of phagocytosis by amphipathic polymeric surfactants.

Authors:  N Watrous-Peltier; J Uhl; V Steel; L Brophy; E Merisko-Liversidge
Journal:  Pharm Res       Date:  1992-09       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.